Micaela Hernberg

8.0k total citations
58 papers, 1.1k citations indexed

About

Micaela Hernberg is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Micaela Hernberg has authored 58 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Oncology, 24 papers in Immunology and 21 papers in Molecular Biology. Recurrent topics in Micaela Hernberg's work include Cancer Immunotherapy and Biomarkers (24 papers), Immunotherapy and Immune Responses (24 papers) and Cutaneous Melanoma Detection and Management (21 papers). Micaela Hernberg is often cited by papers focused on Cancer Immunotherapy and Biomarkers (24 papers), Immunotherapy and Immune Responses (24 papers) and Cutaneous Melanoma Detection and Management (21 papers). Micaela Hernberg collaborates with scholars based in Finland, Sweden and United States. Micaela Hernberg's co-authors include Tero Kivelä, Elina Rantala, Seppo Pyrhönen, Timo Muhonen, Juha Pekka Turunen, Marjo Hahka‐Kemppinen, Steinar Aamdal, Lars Bastholt, Ulrika Stierner and Siru Mäkelä and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Micaela Hernberg

57 papers receiving 1.1k citations

Peers

Countries citing papers authored by Micaela Hernberg

Since Specialization

Citations

This map shows the geographic impact of Micaela Hernberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Micaela Hernberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Micaela Hernberg more than expected).

Fields of papers citing papers by Micaela Hernberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Micaela Hernberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Micaela Hernberg. The network helps show where Micaela Hernberg may publish in the future.

Co-authorship network of co-authors of Micaela Hernberg

This figure shows the co-authorship network connecting the top 25 collaborators of Micaela Hernberg. A scholar is included among the top collaborators of Micaela Hernberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Micaela Hernberg. Micaela Hernberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Adjuvant immunotherapy in the modern management of resectable melanoma: current status and outlook to 2028 2025 ·ESMO Open ·Marco Donia, Henrik Jespersen, Mathilde Jalving, Rebecca Lee, Hanna Eriksson, Christoph Höeller, Micaela Hernberg, (unknown), (unknown), Gabriella Liszkay, Hildur Helgadóttir, (unknown), Dace Pjanova, Iván Márquez‐Rodas, Bart Neyns, Hans M. Westgeest, (unknown), Paweł Sobczuk, Eva Ellebæk, Teresa Amaral	2
2	Intra-patient evolution of tumor microenvironment in the pathogenesis of treatment-naïve metastatic melanoma patients 2023 ·Acta Oncologica ·(unknown), Suvi‐Katri Leivonen, Siru Mäkelä, (unknown), Sirpa Leppä, Micaela Hernberg	1
3	Single-cell characterization of anti–LAG-3 and anti–PD-1 combination treatment in patients with melanoma 2023 ·Journal of Clinical Investigation ·Jani Huuhtanen, (unknown), Katriina Peltola, Tapio Lönnberg, Virpi Glumoff, Oscar Brück, Olli Dufva, Karita Peltonen, (unknown), Emmi Jokinen, Mette Ilander, Moon Hee Lee, Siru Mäkelä, Marta Nyakas, Bin Li, Micaela Hernberg, Petri Bono, Harri Lähdesmäki, Anna Kreutzman, Satu Mustjoki	60
4	Antibiotic Treatment is an Independent Poor Risk Factor in NSCLC But Not in Melanoma Patients Who had Received Anti-PD-1/L1 Monotherapy 2023 ·Clinical Lung Cancer ·(unknown), (unknown), Teemu D. Laajala, (unknown), (unknown), (unknown), (unknown), Leena Tiainen, (unknown), (unknown), (unknown), (unknown), Micaela Hernberg, (unknown), Kalle Mattila	7
5	Determinants of Long-Term Survival in Metastatic Choroidal and Ciliary Body Melanoma 2022 ·American Journal of Ophthalmology ·Elina Rantala, Raffaele Parrozzani, Micaela Hernberg, Vanna Chiarion‐Sileni, Tero Kivelä, Edoardo Midena	3
6	Evolution and modulation of antigen-specific T cell responses in melanoma patients 2022 ·Nature Communications ·Jani Huuhtanen, Liang Chen, Emmi Jokinen, (unknown), Tapio Lönnberg, Anna Kreutzman, Katriina Peltola, Micaela Hernberg, Chunlin Wang, Cassian Yee, Harri Lähdesmäki, Mark M. Davis, Satu Mustjoki	22
7	Viral Molecular Mimicry Influences the Antitumor Immune Response in Murine and Human Melanoma 2021 ·Cancer Immunology Research ·Jacopo Chiaro, (unknown), Thomas Whalley, Cristian Capasso, Mikaela Grönholm, Sara Feola, Karita Peltonen, Firas Hamdan, Micaela Hernberg, Siru Mäkelä, (unknown), Paul E. Brown, Beatriz Martins, Manlio Fusciello, Erkko Ylösmäki, Dario Greco, Anna Kreutzman, Satu Mustjoki, Barbara Szomolay, Vincenzo Cerullo	25
8	Age-associated changes in the immune system may influence the response to anti-PD1 therapy in metastatic melanoma patients 2020 ·Cancer Immunology Immunotherapy ·(unknown), Micaela Hernberg, Siru Mäkelä, Oscar Brück, (unknown), (unknown), Mette Ilander, Satu Mustjoki, Anna Kreutzman	16
9	Overall survival after treatment for metastatic uveal melanoma: a systematic review and meta-analysis 2019 ·Melanoma Research ·Elina Rantala, Micaela Hernberg, Tero Kivelä	169
10	Prospective immunohistochemical analysis of BRAF V600E mutation in melanoma 2014 ·Human Pathology ·Alexandra Thiel, Monica Moza, Soili Kytölä, Arto Orpana, Tiina Jahkola, Micaela Hernberg, Susanna Virolainen, Ari Ristimäki	34
11	Outcome following local recurrence or in-transit metastases in cutaneous melanoma 2012 ·Melanoma Research ·(unknown), Tiina Jahkola, Susanna Virolainen, (unknown), Micaela Hernberg	11
12	Two different durations of adjuvant therapy with intermediate-dose interferon alfa-2b in patients with high-risk melanoma (Nordic IFN trial): a randomised phase 3 trial 2011 ·The Lancet Oncology ·Johan Hansson, Steinar Aamdal, Lars Bastholt, Yvonne Brandberg, Micaela Hernberg, Bo Nilsson, Ulrika Stierner, Hans von der Maase	66
13	Chemoradiotherapy in the treatment of inoperable high-grade osteosarcoma 2010 ·Medical Oncology ·Micaela Hernberg, Aarne Kivioja, Tom Böhling, Rita Janes, Tom Wiklund	8
14	Detection of melanoma‐derived cancer‐testis antigen CT16 in patient sera by a novel immunoassay 2010 ·International Journal of Cancer ·Pekka Rappu, (unknown), (unknown), (unknown), Pia Vihinen, Micaela Hernberg, Tuomas Mirtti, Kalle Alanen, Markku Kallajoki, Meri‐Sisko Vuoristo, Seppo Pyrhönen, Jyrki Heino	6
15	A phase II trial of bevacizumab with dacarbazine and daily low-dose interferon-α2a as first line treatment in metastatic melanoma 2010 ·Melanoma Research ·Pia Vihinen, Micaela Hernberg, Meri‐Sisko Vuoristo, Kristiina Tyynelä, (unknown), Johan Lundin, Johanna Ivaska, Seppo Pyrhönen	43
16	Immunohistochemically Detectable Bcl-2 Expression in Metastatic Melanoma: Association with Survival and Treatment Response 2002 ·Oncology ·Tatyana Vlaykova, Lauri Talve, Marjo Hahka‐Kemppinen, Micaela Hernberg, Timo Muhonen, Yrjö Collan, Seppo Pyrhönen	28
17	Pulmonary toxicity after radiotherapy in primary breast cancer patients: results from a randomized chemotherapy study 2002 ·International Journal of Radiation OncologyBiologyPhysics ·Micaela Hernberg, Pekka Virkkunen, Paula Maasilta, Jani Keyriläinen, Carl Blomqvist, Jonas Bergh, Tom Wiklund	31
18	Subclinical cardiotoxicity following adjuvant dose-escalated FEC, high-dose chemotherapy, or CMF in breast cancer 2000 ·British Journal of Cancer ·Taner Erselcan, (unknown), Tom Wiklund, Micaela Hernberg, Carl Blomqvist, M. Tenhunen, Jonas Bergh, Heikki Joensuu	19
19	Regimens With or Without Interferon-α as Treatment for Metastatic Melanoma and Renal Cell Carcinoma: An Overview of Randomized Trials 1999 ·Journal of Immunotherapy ·Micaela Hernberg, Seppo Pyrhönen, Timo Muhonen	37
20	Prognostic value of biomarkers in malignant melanoma 1998 ·Melanoma Research ·Micaela Hernberg, Juha Pekka Turunen, Kristina von Boguslawsky, Timo Muhonen, (unknown)	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact